HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna De Ponti Selected Research

NMS-E973

7/2013NMS-E973, a novel synthetic inhibitor of Hsp90 with activity against multiple models of drug resistance to targeted agents, including intracranial metastases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna De Ponti Research Topics

Disease

4Neoplasms (Cancer)
11/2013 - 05/2010
1Brain Neoplasms (Brain Tumor)
07/2013
1Melanoma (Melanoma, Malignant)
07/2013
1Neoplasm Metastasis (Metastasis)
07/2013
1Disease Progression
07/2013
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2012
1Colonic Neoplasms (Colon Cancer)
04/2012
1Hematologic Neoplasms (Hematological Malignancy)
04/2012
1Carcinogenesis
05/2010

Drug/Important Bio-Agent (IBA)

2Phosphotransferases (Kinase)IBA
07/2013 - 04/2012
2Polo-Like Kinase 1IBA
04/2012 - 05/2010
1Proteins (Proteins, Gene)FDA Link
11/2013
1compound 18IBA
11/2013
1Pharmaceutical PreparationsIBA
07/2013
1NMS-E973IBA
07/2013
1Irinotecan (Camptosar)FDA LinkGeneric
04/2012
1NMS P937IBA
04/2012
1Cytarabine (Cytosar-U)FDA LinkGeneric
04/2012

Therapy/Procedure

2Oral Administration
04/2012 - 05/2010